Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Bristol-Myers Squibb (NY: BMY ) 44.04 +0.14 (+0.32%) Official Closing Price Updated: 6:30 PM EDT, May 7, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Bristol-Myers Squibb < Previous 1 2 3 4 5 6 7 8 9 ... 41 42 Next > Health Care Company Bristol-Myers Squibb Announces Merger With Karuna Therapeutics December 22, 2023 Via Benzinga Dow Rises 50 Points; Fed's Preferred Inflation Gauge Cools In November December 22, 2023 U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 50 points on Friday. Following the market opening Friday, the Dow traded up 0.14% to 37,458.12 while the NASDAQ rose... Via Benzinga Topics Economy Stocks Exposures Interest Rates US Equities Bristol Myers Squibb Scoops Up Schizophrenia Player Karuna Therapeutics In Massive $14B Deal December 22, 2023 On Friday, Bristol Myers Squibb & Co (NYSE: BMY) agreed to acquire Karuna Therapeutics Inc (NASDAQ: KRTX) for $330.00 per share in cash, for a total equity value of $14.0 billion, or $12.7 billion n Via Benzinga Karuna Stock Soars On Bristol Myers' $14 Billion Takeover December 22, 2023 Karuna is working on treatments for schizophrenia and Alzheimer's disease psychosis. Via Investor's Business Daily 3 Potential Turnaround Stocks to Buy for Big Rewards in 2024 December 20, 2023 There was plenty to get excited about in 2023 and even more to get excited about with turnaround stocks in the new year. Via InvestorPlace A Closer Look at Bristol-Myers Squibb's Options Market Dynamics December 15, 2023 Via Benzinga Is Bristol Myers Squibb Stock a Buy Now? December 15, 2023 The answer might depend on the kind of investor you are. Via The Motley Fool Is NYSE:BMY a Good Fit for Dividend Investing? December 14, 2023 Balancing Dividends and Fundamentals: The Case of BRISTOL-MYERS SQUIBB CO (NYSE:BMY). Via Chartmill Better Dividend Stock: Bristol Myers Squibb or Merck? December 19, 2023 These two pharma stocks have sizable dividend yields. Which is the better buy right now? Via The Motley Fool Jim Cramer Slams FTC Chair Lina Khan's Policies For Hampering Investor Returns: 'One-Woman Wrecking Crew For Your Stock Portfolio' December 18, 2023 He posits that such actions have negatively impacted stock valuations. Via Benzinga 7 Stocks with Strong Insider Buying: December 2023 December 17, 2023 Here are just a few of the top stocks with strong insider buying that all investors may want to watch heading into 2024. Via InvestorPlace Week in Review: SystImmune Out-Licenses Global Rights for ADC to BMS in $8.4 Billion Deal December 16, 2023 SystImmune, the Seattle arm of Chengdu’s Biokin Pharma, out-licensed global rights (ex-China) for a bispecific ADC to Bristol Myers Squibb in a $8.4 billion agreement. Via Talk Markets Bristol Myers Squibb Further Diversifies Oncology Portfolio With Mega $8.4B Deal December 12, 2023 SystImmune and Bristol Myers Squibb & Co (NYSE: BMY) Via Benzinga Bristol-Myers Squibb Unusual Options Activity November 27, 2023 Via Benzinga Exploring NYSE:BMY's dividend characteristics. November 22, 2023 Why BRISTOL-MYERS SQUIBB CO (NYSE:BMY) qualifies as a good dividend investing stock. Via Chartmill This 1 Emerging Risk Could Be a Problem for These 3 Big Pharma Stocks December 10, 2023 Regulators are already on the case, and their findings will have financial impacts. Via The Motley Fool 3 Dividend Stocks Trading at 52-Week Lows December 09, 2023 All three of these companies have seen brighter days. Via The Motley Fool Insiders Buying Bristol-Myers Squibb And 3 Other Stocks December 08, 2023 Although U.S. stocks closed higher on Thursday, there were a few notable insider trades. Via Benzinga Why Bristol Myers Squibb's Shares Are Gaining Today? December 07, 2023 Bristol Myers Squibb & Co (NYSE: BMY) released topline data from Phase 3 CheckMate -8HW trial of Opdivo (nivolumab) plus Yervoy (ipilimumab) compared to the investigator’s choice of chemotherapy as a... Via Benzinga Pharma Industry on Alert as Biden Administration Explores Patent Seizure Powers December 07, 2023 The White House is endorsing a contentious power that permits the government to reclaim patents for specific Via Benzinga Topics Intellectual Property Exposures Intellectual Property 2024's Potential Stock Surprises: Goldman Sachs Unveils S&P 500 Laggards For Major Gains December 06, 2023 Investors hunt for new opportunities in stocks that have been discounted & now present promising options for recovery. Via Benzinga Topics Stocks Exposures US Equities 3 Dirt-Cheap Stocks That Could Skyrocket December 05, 2023 Low valuations don't always guarantee gains are in the offing. You need a company firing on all cylinders, too. Via The Motley Fool Can Bristol Myers Squibb Keep Its Streak Alive? November 29, 2023 Bristol Myers Squibb is a $100 billion market cap pharmaceutical company that has raised its dividend every year since 2010 and has paid one since 1933. Via Talk Markets Eyes On Novartis, Gilead, Bristol Myers As FDA Weighs Risks Vs. Benefits Of Approved CAR T-Cell Therapies November 29, 2023 Tuesday, the FDA said it received reports of patients developing T-cell malig Via Benzinga Exposures Product Safety Why Is Avidity Biosciences (RNA) Stock Up 15% Today? November 28, 2023 RNA stock is jumping over 15% in early trading after Avidity announced its expanded alliance with Bristol-Myers Squibb. Via InvestorPlace Why Is RNA Therapeutics-Focused Avidity Biosciences Stock Trading Higher Today? November 28, 2023 Avidity Biosciences Inc (NASDAQ: RNA) announced a global licensing and research collaboration with Bristol Myers Squibb & Co (NYSE: BMY) focused on discovering, developing, and commercializing multiple... Via Benzinga Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 4% Dividend Yields November 27, 2023 During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high... Via Benzinga 3 Resilient Stocks with Massive Potential to Boost Your Wealth November 26, 2023 These three stocks with massive potential can make patient investors fabuslously wealthy as they come roaring back to life. Via InvestorPlace Don't Wait for a Market Crash: These 2 Top Stocks Are on Sale November 24, 2023 Sometimes the stock market offers its own version of Black Friday deals. Via The Motley Fool $1M Bet On Iridium Communications? Check Out These 3 Stocks Insiders Are Buying November 22, 2023 Although U.S. stocks closed lower on Tuesday, there were a few notable insider trades. Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 ... 41 42 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.